At the frontiers of lung fibrosis therapy

Nature Biotechnology

Volumn 31, Issue 9, 2013, Pages 781-783

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; INTERLEUKIN 10; LYSOPHOSPHATIDIC ACID; NINTEDANIB; PENTRAXIN; PIRFENIDONE; POLYSTYRENE; PREDNISONE; PROSTAGLANDIN E; SIMTUZUMAB; TRALOKINUMAB; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; COLLAGEN SYNTHESIS; CYTOKINE PRODUCTION; DIARRHEA; DISEASE COURSE; EVIDENCE BASED PRACTICE; EXTRACELLULAR MATRIX; FOOD AND DRUG ADMINISTRATION; FORCED VITAL CAPACITY; HEALTH CARE QUALITY; HOSPITALIZATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; INFLAMMATORY CELL; KNOCKOUT MOUSE; LUNG BIOPSY; LUNG FIBROSIS; LUNG FUNCTION; LUNG TRANSPLANTATION; MESENCHYME CELL; MOUSE MODEL; MYOFIBROBLAST; NAUSEA AND VOMITING; NONHUMAN; OPTIMISM; PHAGOCYTE; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PHENOTYPE; POSITIVE FEEDBACK; PRIORITY JOURNAL; PULMONOLOGIST; QUALITY OF LIFE; SCAR FORMATION; TARGET ORGAN; TISSUE INJURY; UNITED STATES; WOUND HEALING;

AMINO ACID OXIDOREDUCTASES; ANTIBODIES, MONOCLONAL; APOPTOSIS; BIOMEDICAL RESEARCH; DRUG DELIVERY SYSTEMS; HUMANS; PULMONARY FIBROSIS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84884167456     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt.2687     Document Type: Article

References (8)

1. N oble, P.W. et al. Lancet 377, 1760-1769 (2011).
2. R aghu, G. et al. Am. J. Respir. Crit. Care Med. 183, 788-824 (2011).
3. Barry-Hamilton, V. et al. Nat. Med. 16, 1009-1017 (2010).
4. Tager, A.M. et al. Nat. Med. 14, 45-54 (2008).
5. R icheldi, L. et al. N. Engl. J. Med. 365, 1079-1087 (2011).
6. Maher, T.M. Eur. Respir. Rev. 22, 148-152 (2013).
7. Idiopathic Pulmonary Fibrosis Clinical Research Network. N. Engl. J. Med. 366, 1968-1977 (2012).
8. Van Den Blink, B. et al. American Thoracic Society meeting abstract A5707 (2013).